Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02760654 · ClinicalTrials.gov registry record · NA
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02760654 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT02760654, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this pilot randomized wait-list controlled trial is to test the efficacy of an online cognitive behavioral pain management website called Proactive Self-Management Program for Effects of Cancer Treatment (PROPSECT) to reduce worst pain intensity for individuals with chronic painful chemotherapy-induced peripheral neuropathy (CIPN) and to explore the mediating effect of PROSPECT-induced changes in anxiety, fatigue, depression, and sleep disturbance on worst pain intensity. Another aim of this study is to determine whether PROSPECT will decrease CIPN symptom severity (e.g. non-painful numbness and tingling), average pain severity, and physical impairment. Lastly, since this intervention has never been tested in individuals with painful CIPN, the investigators will assess patients' perceptions of acceptability and satisfaction with the intervention.
Interventions
- DEVICE Proactive Self Management Program for Effects of Cancer Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02760654
The ClinicalTrials.gov registry entry for NCT02760654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proactive Self Management Program for Effects of Cancer Treatment is the first listed.
NCT02760654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02760654 about?
NCT02760654 is a clinical study titled "Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy". The purpose of this pilot randomized wait-list controlled trial is to test the efficacy of an online cognitive behavioral pain management website called Proactive Self-Management Program for Effects of Cancer Treatment (PROPSECT) to reduce worst pain intensity for individuals with chronic painful ch...
What is the current status of trial NCT02760654?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02760654?
The interventions under investigation include: Proactive Self Management Program for Effects of Cancer Treatment (DEVICE).
Who is sponsoring clinical trial NCT02760654?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.